Found 42 Enz. Inhib. hit(s) with all data for entry = 50003018 
Affinity DataIC50: 6.10nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 7.10nMAssay Description:Inhibition of mouse GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 9.10nMAssay Description:Inhibition of rat GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 9.20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 27nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 38nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 59nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 62nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 62nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 66nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 74nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 89nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 97nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 152nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 214nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 308nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 593nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 935nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 3.28E+3nMAssay Description:Inhibition of human GSNOR assessed as reduction in NADH consumption after 3 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetAll-trans-retinol dehydrogenase [NAD(+)] ADH1B(Homo sapiens (Human))
Glenmark Pharmaceuticals
Curated by ChEMBL
Glenmark Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.40E+4nMAssay Description:Inhibition of ADH1B (unknown origin) assessed as reduction in NADH production by spectrophotometric analysisMore data for this Ligand-Target Pair
